v3.25.3
RESTRUCTURING
 9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
RESTRUCTURING RESTRUCTURING
During the three and nine months ended September 30, 2025, the Company recognized restructuring costs related to a reduction-in-force and certain departmental reorganizations totaling $4.4 million and $7.5 million, respectively. During the three months ended March 31, 2024, the Company recognized restructuring costs relating to a reduction-in-force totaling $2.2 million. There were no restructuring costs recognized during the three months ended September 30, 2024. One-time termination benefits provided in all cases included severance, continuation of health insurance coverage and other benefits for a specified period of time.
Restructuring costs have been recognized in the accompanying consolidated statement of operations as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
 (In thousands)
Restructuring costs:
Cost of revenue$270 $— $360 $88 
Research and development expense2,078 — 2,783 116 
Sales and marketing expense1,796 — 2,822 1,104 
General and administrative expense291 — 1,515 897 
Total$4,435 $— $7,480 $2,205 
At September 30, 2025, a payable of $2.9 million related to restructuring costs was included in "Accrued expenses and other current liabilities" in the accompanying consolidated balance sheet.